Anti-inflammatory activity of antifungal preparations

International Journal of Dermatology

Volumn 36, Issue 10, 1997, Pages 788-792

  Rosen, Ted ^a,b   Schell, Barbara J ^a   Orengo, Ida ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; KETOCONAZOLE;

ANTIINFLAMMATORY ACTIVITY; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ERYTHEMA; EXPOSURE; NONHUMAN; ULTRAVIOLET RADIATION;

EID: 0030715379     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1997.00309.x     Document Type: Conference Paper

References (26)

1. Samson C, Peets E, Winter-Sperry R, et al. Clotrimazole/ betamethasone dipropionate-lotrisone - an antifungal/ steroid combination for treatment of cutaneous dermatophyte infections. In: Maibach HI, ed. Topical Corticosteroids. Basel: Karger, 1992: 318-334.
2. Beetens JR, Loots W, Somers Y, et al. Ketoconazole inhibits the biosynthesis of leukotrienes in-vitro and in-vivo. Biochem Pharmacol 1986; 35: 883-891.
3. Bremm KD, Plempel M. Modulation of leukotriene metabolism from human polymorphonuclear granulocytes, by bifonazole. Mycoses 1991; 34: 41-45.
4. Hegemann L, Toso SM, Lahijani KI, et al. Direct interaction of antifungal azole derivatives to calmodulin: a possible mechanism for their therapeutic activity. J Invest Dermatol 1993; 100: 343-346.
5. Solomon BA, Lee WL, Geen SC, et al. Modification of neutrophil functions by naftifine. Br J Dermatol 1993; 128: 393-398.
6. Steinhilber D, Jaschonek K, Knospe J, et al. Effects of novel antifungal azole derivatives on the 5-lipoxygenase and cyclooxygenase pathways. Drug Research 1990; 40: 1260-1263.
7. Abrams BB, Hanel H, Hoehler T. Ciclopirox olamine: a hydroxypyridone antifungal agent. Clin Dermatol 1991; 9: 471-477.
8. Smith-Kurtz E, Maddalena ME, Hellyer L, et al. Evaluation and comparison of the anti-inflammatory activity of antimycotic agents. Poster Exhibit, American Academy of Dermatology, 1991.
9. Van Cutsem J, Van Ferven F, Cauwenbergh G, et al. The anti-inflammatory effects of ketoconazole: a comparative study with hydrocortisone acetate in a model using living and killed Staphylococcus aureus on the skin of guinea pigs. J Am Acad Dermatol 1991; 25: 257-261.
10. Evans EGV, James IGV, Seaman RAJ, et al. Does naftifine have anti-inflammatory properties? A double-blind comparative study with 1% clotrimazole-1% hydrocortisone in clinically diagnosed fungal infections of the skin. Br J Dermatol 1993; 129: 437-442.
11. Friedrich HC, Haas PJ, Tronnier HA. Comparison of treatment with naftifine and with a combination of a corticosteroid and an imidazole derivative. Aktuel Dermatol 1985; 11: 77-80.
12. Lassus A, Nolting KS, Saropoulos C. Comparison of ciclopirox olamine 1% cream with ciclopirox 1%-hydrocortisone acetate 1% cream in the treatment of inflamed superficial mycoses. Clin Therapeutics 1988; 10: 594-599.
13. Mertens RIJ, Morias J, Verhamme G. A double-blind study comparing Daktacort, miconazole and hydrocortisone in inflammatory skin infections. Dermatologica 1976; 153: 228-235.
14. Smith EB, Breneman DL, Griffith RF, et al. Double-blind comparison of naftifine cream and clotrimazole/ betamethasone dipropionate cream in the treatment of tinea pedis. J Am Acad Dermatol 1992; 26: 125-127.
15. Tronnier H. Inflammatory dermatomycoses: comparative study of naftifine and a combination of a corticosteroid and an imidazole derivative. Mykosen 1987; 30 (Suppl 1): 78-87.
16. Nada M, Hanafi S, Al-Omari H, et al. Naftifine versus miconazole/hydrocortisone in inflammatory dermatophyte infections. Int J Dermatol 1994; 33: 570-572.
17. Hegemann L, Stettendorf S. The use of antifungal azole derivatives in inflammatory skin disorders. J Geriatric Dermatol 1993; 1: 28-37.
18. Jung EG. The anti-inflammatory efficacy of naftifine as evaluated from the erythema response to ultraviolet light. Mykosen 1987; 30 (Suppl 1): 88-91.
19. Petri H, Tronnier H, Haas P. Investigations into the anti-inflammatory effect of bifonazole. In: Hay RJ, ed. Advances in Topical Antifungal Therapy. Berlin-Heidelberg: Springer-Verlag, 1986: 26-31.
20. Krebs S, Greenberg J, Jesrani K. Temporal correlation of lymphocyte blastogenesis, skin test response and erythema during dermatophyte infections. Clin Exp Immunol 1977; 26: 526-530.
21. Dahl MV. Immunological resistance to dermatophyte infections. Adv Dermatol 1987; 2: 305-320.
22. Jones HE. Immune response and host resistance of humans to dermatophyte infection. J Am Acad Dermatol 1993; 28: S12-S19.
23. Calderon RA. Immunoregulation of dermatophytosis. Crit Rev Microbiol 1989; 16: 339-368.
24. Swan JW, Dahl MV, Coppo PA, et al. Complement activation by Trichophytin rubrum. J Invest Dermatol 1983; 80: 156-158.
25. Dahl MV, Carpenter R. Polymorphonuclear leukocytes, complement, and Trichophytin rubrum. J Invest Dermatol 1986; 86: 138-141.
26. Petri H, Bremm KD, Haas PJ, et al. Experimentelle und klinische Untersuchungen uber die antiphlogistische Wirking von Bifonazol. Z Hautkr 1991; 66: 150-156.